Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Investor Presentation

Hexagon Nutrition Investor Presentation: Key Takeaways

Hexagon Nutrition reported Q1 FY27 revenue of ₹1,043 Mn with 11.3% EBITDA margin. The firm focuses on specialized clinical and wellness nutrition brands like Pentasure and Pediagold.

Highlights
Revenue growth43.16% YoY
MarginsEBITDA margin 11.31% vs 13.81% YoY.
Demand visibilityRising NCDs and ageing population fueling clinical nutrition demand.

Growth

Revenue grew 43.16% YoY to ₹1,043.06 Mn; PAT increased 25.07% YoY to ₹80.73 Mn.

Outlook

Targeting 15%+ medium-term EBITDA margins through improved B2C mix (>35% of revenue) and operational leverage.

Risks

Challenges include regional nutritional gaps, consumer misinformation, and high dependence on domestic markets for raw materials.

Source

Investor Presentation filed with NSE, NSE: HEXAGON. Summary written with AI assistance from the document.

Read the document ↗

Hexagon Nutrition Ltd: key numbers

Share price
₹65.10
Market cap
₹800.2 Cr
Revenue (annual)
₹382.6 Cr
Net profit (annual)
₹37.94 Cr
P/E (TTM)
20.2×Sector 43.4×
Promoter holding
64.29%
FII holding
0.29%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Hexagon Nutrition Ltd

All →
21:42 IST BSE
Board Meeting Date

Hexagon Nutrition Board Meeting Date

Hexagon Nutrition Ltd has scheduled a Board Meeting for September 30, 2026, to discuss requisition letters for appointing directors and approving remuneration.

23:23 IST BSE
Management Change

Hexagon Nutrition Management Change

Hexagon Nutrition Limited announced the appointment of an Executive Director, re-appointment of a Joint Managing Director, and the appointment of a Secretarial Auditor.

20:00 IST BSE
Other Announcement

Hexagon Nutrition Other Announcement

Hexagon Nutrition informed exchanges that its promoters abstained from voting on certain resolutions. The company is currently seeking independent legal advice regarding this matter.

20:22 IST BSE
Annual General Meeting

Hexagon Nutrition Annual General Meeting

Hexagon Nutrition Limited held its 33rd Annual General Meeting on September 22, 2026. The meeting transacted business as listed in the AGM notice.

15:13 IST BSE
Promoter Buying

Hexagon Nutrition Promoter Buying: ₹0.26 Cr

Promoters and promoter group members of Hexagon Nutrition Ltd purchased 40,000 equity shares via open market transactions, with a total consideration of ₹0.26 Crore.

Value
₹0.26 Cr
12:18 IST BSE
Promoter Buying

Hexagon Nutrition Promoter Buying

Dr. Nikhil Kelkar, promoter and joint MD of Hexagon Nutrition, acquired 10,000 equity shares in the open market. His stake rose from 17.27% to 17.28%.

Promoter stake change
+0.01%